Skip to main content

EDITORIAL article

Front. Oncol., 11 July 2024
Sec. Gastrointestinal Cancers: Colorectal Cancer
This article is part of the Research Topic Multimodal Treatment of Recurrence and Distant Metastases of Colorectal Cancer View all 11 articles

Editorial: Multimodal treatment of recurrence and distant metastases of colorectal cancer

Andrea Balla,*&#x;Andrea Balla1,2*†Diletta Corallino,&#x;Diletta Corallino3,4†Diego Coletta&#x;Diego Coletta5†Pierpaolo Sileri&#x;Pierpaolo Sileri6†Salomone Di Saverio&#x;Salomone Di Saverio7†Salvador Morales-Conde,&#x;Salvador Morales-Conde1,2†
  • 1Department of General and Digestive Surgery, University Hospital Virgen Macarena, University of Sevilla, Sevilla, Spain
  • 2Unit of General and Digestive Surgery, Hospital Quirónsalud Sagrado Corazón, Sevilla, Spain
  • 3Department of General Surgery and Surgical Specialties “Paride Stefanini”, Sapienza University of Rome, Rome, Italy
  • 4Hepatobiliary Surgery Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy
  • 5Hepatopancreatobiliary Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy
  • 6Colorectal Surgery Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy
  • 7Azienda Sanitaria Unica Regionale (ASUR) Marche 5, San Benedetto del Tronto General Hospital, San Benedetto del Tronto, Italy

For the treatment of rectal cancer and recurrence or distant metastases several critical improvements have been developed in the last decades. Since the first milestone intervention proposed by Miles more than one hundred years ago, for the treatment of low rectal tumors, surgery has made great progress with the introduction of low anterior resection with Knight and Griffits anastomosis, colonic pouches, intersphincteric resection, the introduction of the minimally invasive approach by laparoscopy or by robot, the use of transanal device, or the use of fluorescence angiography and lymphangiography, up to the use of artificial intelligence intraoperatively (13). However, we must not forget maybe the most important advance in the treatment of rectal cancer such as the description by Heald in the 80’s of the concept of total mesorectal excision (TME) (4). In fact the introduction of this new paradigm was a sliding door for the oncological results allowing to reduce drastically the recurrence rate after surgery (4). Similarly the introduction of the neoadjuvant chemo-radiotherapy (n-CRT) contributed to reduce dramatically the recurrence rate (4).

Anyway, rectal cancer, apart from local recurrence, is also responsible for distant metastases, especially liver metastases, and in the last years a great effort has been made to investigate about the tumor biology, in order to improve survival and disease free survival of these patients. I want to thank to Frontiers in Oncology to have the opportunity to serve as Editor of this monographic issue about the multimodal treatment of recurrence and distant metastases of colorectal cancer, and I want to thank all authors involved.

Important findings are reported in this Research Topic by using nomograms and machine learning, about the prediction of the survival outcomes for patients affected by young-onset colorectal cancer with the aim to assist in developing clinical treatment strategies for these patients (Li et al.), and about the prediction of distant metastatic sites and risk facilitating the clinical decision-making process (He et al. and Qiu et al., respectively).

On the other hand, Dai et al., He et al., Gao et al., and Zhou et al. focused their findings on the use of new protocol of immunotherapy, chemotherapy and radiotherapy for the treatment of metastatic colorectal cancer with encouraging results.

Li et al. reported an interesting literature review about acupuncture showing its use for the treatment of colorectal cancer symptoms, while Xu et al. reported as positive clinical circumferential resection margin is an independent risk factor for recurrence after TME. Finally, Baba et al. reported as irinotecan induced interstitial lung disease even in a patients underwent bone marrow transplantation for aplastic anemia decades before.

Treatment of rectal cancer, especially in case of local recurrence or distant metastases is still a debated topic and further topics will be of interest in the future, however, we considered that the present issue includes high-quality studies. We hope that this monographic issue will be of interest for the reader, helping to update the most advanced knowledge on rectal cancer treatment.

Author contributions

AB: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. DCor: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. DCol: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. PS: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. SDS: Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing, Conceptualization, Data curation, Formal analysis. SM-C: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Paganini AM, Balla A, Quaresima S, D'Ambrosio G, Bruzzone P, Lezoche E. Tricks to decrease the suture line dehiscence rate during endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM). Surg Endosc. (2015) 29:1045–50. doi: 10.1007/s00464-014-3776-3

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Morales-Conde S, Licardie E, Alarcón I, Balla A. Indocyanine green (ICG) fluorescence guide for the use and indications in general surgery: recommendations based on the descriptive review of the literature and the analysis of experience. Cir Esp (Engl Ed). (2022) 100:534–54. doi: 10.1016/j.cireng.2022.06.023

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Morales-Conde S, Alarcón I, Yang T, Licardie E, Balla A. A decalogue to avoid routine ileostomy in selected patients with border line risk to develop anastomotic leakage after minimally invasive low-anterior resection: A pilot study. Surg Innov. (2020) 27:44–53. doi: 10.1177/1553350619890720

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Cosimelli M, Ursi P, Mancini R, Pattaro G, Perri P, Parrino C, et al. Organ-saving surgery for rectal cancer after neoadjuvant chemoradiation: Analysis of failures and long-term results. J Surg Oncol. (2020) 121:375–81. doi: 10.1002/jso.25794

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: rectal cancer (RC), chemotherapy, radiotherapy, local recurrence, distant metastases

Citation: Balla A, Corallino D, Coletta D, Sileri P, Di Saverio S and Morales-Conde S (2024) Editorial: Multimodal treatment of recurrence and distant metastases of colorectal cancer. Front. Oncol. 14:1455405. doi: 10.3389/fonc.2024.1455405

Received: 26 June 2024; Accepted: 03 July 2024;
Published: 11 July 2024.

Edited and Reviewed by:

Yun Dai, Peking University, China

Copyright © 2024 Balla, Corallino, Coletta, Sileri, Di Saverio and Morales-Conde. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Andrea Balla, andrea.balla@gmail.com

ORCID: Andrea Balla, orcid.org/0000-0002-0182-8761
Diletta Corallino, orcid.org/0000-0002-4937-4332
Diego Coletta, orcid.org/0000-0002-9116-0733
Pierpaolo Sileri, orcid.org/0000-0002-1104-6237
Salomone Di Saverio, orcid.org/0000-0001-5685-5022
Salvador Morales-Conde, orcid.org/0000-0003-2833-0717

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.